Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
Submitted by
admin
on March 3, 2024 - 9:48pm
Source:
Motley Fool
News Tags:
Ozempic
Abbott Labs
Medtech
diabetes
CGMs
Headline:
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
snippet:
Abbott's most important franchise works well in combination with weight-loss treatments.
The company is also looking to address another problem these medicines create.
There are many reasons to invest in Abbott, including its innovative qualities and the dividend.
Do Not Allow Advertisers to Use My Personal information